诺华斥资2.7亿美元收购Avidity,获得两项临床前心血管候选药物,心房项目应运而生。
Atrium arises from Novartis' Avidity buy with $270M, pair of preclinical cardio candidates
生物技术与制药领域的最新动态
Atrium arises from Novartis' Avidity buy with $270M, pair of preclinical cardio candidates
Lilly debuts Nvidia supercomputer with fanfare and focus on escaping traditional pharma lifecycle
Novartis, Takeda to enter next Medicare drug price negotiations
Illumina Partners with SPT Labtech, Takara Bio on Automated Sample Prep and Spatial Transcriptomics - GEN - Genetic Engineering and Biotechnology News
Thermo Fisher’s TacroType Test Adds Precision Medicine Angle To TMO Story - simplywall.st
US International Trade Commission to take a closer look at Chinese biotech
Merck cuts more than 150 jobs at new Gardasil vaccine plant in North Carolina
CHMP recommends Moderna's flu-Covid shot and Novartis pill for hives
Atrium spins out of Avidity, aiming to target rare heart diseases with RNA
Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics - PR Newswire APAC - PR Newswire Asia
UniQure falls further on Makary comments
Biopharma money raised: Jan. 1-Feb. 26, 2026
Money raised by biopharma
Moderna’s combination flu, COVID shot wins over European drug regulators
Generate:Biomedicines raises $400M IPO, CEO talks about AI's future in drug design
Illumina: Competitive Pressures Mounting but 2026 Revenue Targets Still Intact, Justifying a Hold Rating - TipRanks
Chutes & Ladders—Sarepta CEO to step down as DM1 hits close to home
FDA slams ExThera with warning letter over controversial blood filter device
Thermo Fisher extends two leases in Middleton - The Daily Reporter
Ginkgo divests biosecurity arm; J&J's early prostate cancer data